戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              PLC activity was found to depend upon the electrostatic
2                                              PLC localization is largely intracellular and its compar
3                                              PLC-beta isoforms also function as GTPase-activating pro
4                                              PLC-derived organoid cultures preserve the histological
5                                              PLC-derived organoids are amenable for biomarker identif
6                                              PLC/inositol trisphosphate receptor (IP3R) and estrogen
7 sms regulating the sensitivity to GPCR-Gq/11-PLC-dependent gating of a receptor-operated channel.
8 for conferring the sensitivity to GPCR-Gq/11-PLC-dependent gating on TRPC5.
9 scues the mutant's sensitivity to GPCR-Gq/11-PLC-dependent gating.
10 e I, II, and III taste bud cells (NTPdase 2, PLC-beta2, and AADC, respectively).
11              This inhibition is blocked by a PLC inhibitor (U73122, 1-(6-{[(17beta)-3-Methoxyestra-1,
12 Moreover, we determined that GLP-1 activates PLC, which increases submembrane diacylglycerol and ther
13 w that Ca(2+) influx through TRPV1 activates PLC and DAGK enzymes and that the latter limits formatio
14 and free fatty acids into gum bilayers after PLC and 3G ED.
15  to identify both orthosteric and allosteric PLC inhibitors.
16 on detection of coincident Gi/o, Ca(2+), and PLC signaling, which is further modulated by the small G
17  activated TrkB and downstream AKT, ERK, and PLC-gamma signaling in TNBC cells, increasing their inva
18  show that WNT signaling through Galphao and PLC-beta results in sustained Ca(2+) release via IP(3) a
19 cate that the mechanism by which Galphaq and PLC-beta3 mutually regulate each other is far more compl
20  turn, aberrant activation of PLC-gamma1 and PLC-gamma2 is implicated in inflammation, autoimmunity,
21 on followed by G(q) immunoprecipitation, and PLC activation by determining the inositol phosphate lev
22 horylated Src-family kinases (pSFK), LAT and PLC-gamma over T cell receptor (TCR) alone.
23 aused by manipulating beta2AR, D5R, M1R, and PLC.
24        The effects of co-infusing mGluR1 and PLC inhibitors were additive, whereas those of coinhibit
25 ve, whereas those of coinhibiting mGluR5 and PLC were not, indicating that the efficacy of mGluR1 blo
26  beta(2) integrin activation (PKC, PI3K, and PLC) were similarly activated in both T cell subsets.
27 tion-dependently activated G(q) proteins and PLC in the hypothalamus and cerebellum but not in cortex
28                                     Rac1 and PLC are required for nutritional use of extracellular pr
29 stream signaling proteins, such as Zap70 and PLC-gamma1.
30              Mammalian phospholipase C-beta (PLC-beta) isoforms are stimulated by heterotrimeric G pr
31 me Rho family GTPases, phospholipase C-beta (PLC-beta) isoforms hydrolyze phosphatidylinositol 4,5-bi
32                        Phospholipase C-beta (PLC-beta) isozymes hydrolyze the membrane lipid phosphat
33 e was found for a direct interaction between PLC and the GTPases that mediate phospholipase activatio
34  block a highly specific interaction between PLC delta1-PH and PI(4,5)P2, encoded within the conforma
35 or the first time, the relationships between PLC activity and substrate presentation in lipid vesicle
36 ral studies showed how Galphaq and Rac1 bind PLC-beta, there is a lack of consensus regarding the Gbe
37 ld standard (using kits from Trinity Biotech PLC, Wicklow, Ireland) were included.
38                                         BtPI-PLC carries a negative net charge and its interfacial bi
39                                         BtPI-PLC interactions with the SUV surface are transient with
40 ific electrostatic interactions between BtPI-PLC and membranes vary as a function of the fraction of
41 tidylinositol-specific phospholipase C (BtPI-PLC) is a secreted virulence factor that binds specifica
42 tidylinositol-specific phospholipase C (BtPI-PLC), which specifically binds to phosphatidylcholine (P
43 esults lead to a quantitative model for BtPI-PLC interactions with cell membranes where protein bindi
44 at weak electrostatics, as observed for BtPI-PLC, might be a less unusual mechanism for peripheral me
45                        To elucidate how BtPI-PLC searches for GPI-anchored proteins on the membrane s
46 -atom molecular dynamics simulations of BtPI-PLC interacting with PC-rich bilayers show that the prot
47            These data also suggest that BtPI-PLC does not directly sense curvature, but rather prefer
48 phate (PIP(2) ), the substrate hydrolysed by PLC, and intracellular Ca(2+) .
49 tly activated by diacylglycerols produced by PLC breakdown of phosphatidylinositol 4,5-bisphosphate (
50 either by serotonin-induced phospholipase C (PLC) activation or by a rapamycin-induced translocation
51 inating in phosphoinositide-phospholipase C (PLC) activation, which generates the second messengers d
52 depletion of PI(4,5)P2 upon phospholipase C (PLC) activation.
53 ate (IP3 ) accumulation and phospholipase C (PLC) activity were significantly potentiated in hepatocy
54 n Drosophila is mediated by phospholipase C (PLC) and Ca(2+)-permeable TRP channels, but the function
55 he same receptors activated phospholipase C (PLC) and decreased plasma membrane PI(4,5)P(2) levels in
56 ates Duox1 activity through phospholipase C (PLC) and intracellular calcium signaling in vivo.
57  mediated by G proteins and phospholipase C (PLC) beta1.
58 e receptor to activation of phospholipase C (PLC) but not phospholipase D (PLD).
59 ctivate a calcium-sensitive phospholipase C (PLC) enzyme and to lead to a robust decrease in phosphat
60                             Phospholipase C (PLC) enzymes are key virulence factors in several pathog
61 the GPVI signaling effector phospholipase C (PLC) gamma2.
62 (2+) -induced activation of phospholipase C (PLC) has been implied in the regulation of TRPM8 channel
63 ] and were not perturbed by phospholipase C (PLC) inhibition.
64  prevented by BAPTA-AM or a phospholipase C (PLC) inhibitor.
65 s also inhibited by using a phospholipase C (PLC) inhibitor.
66   Phosphoinositide-specific phospholipase C (PLC) is an important family of enzymes constituting a ju
67  tyrosine kinases, activate phospholipase C (PLC) isozymes to hydrolyze phosphatidylinositol 4,5-bisp
68 upled receptor (GPCR)-Gq/11-phospholipase C (PLC) pathway.
69 nd -5 via the Gq/11 protein-phospholipase C (PLC) signaling pathway has remained elusive so far.
70 ch melatonin transactivates phospholipase C (PLC) through 5-HT(2C) .
71  treatment with buffer-free phospholipase C (PLC) to near-quantitatively degrade PCs in fresh-frozen
72               Inhibition of phospholipase C (PLC) with U73122 did not inhibit either ImAHP or IsAHP i
73 ly a substrate for PI3K and phospholipase C (PLC), and is now an established lipid messenger pivotal
74 lglycerol lipase (DAGL), or phospholipase C (PLC), and their metabolism is mediated by several metabo
75  thought to be regulated by phospholipase C (PLC), but neither the specific PLC isoform nor the in vi
76                     For ED, phospholipase C (PLC), phospholipase A2 (PLA2) and a mixture of phospholi
77  by inhibitors of Src, PKC, phospholipase C (PLC), PI3K, or soluble MMPs.
78 is by a specific isoform of phospholipase C (PLC), PLCepsilon, at the nuclear envelope.
79 owth factor (FGF) receptor, phospholipase C (PLC), protein kinase C (PKC) and phosphoinositide-3-kina
80 r classes of effectors, the phospholipase C (PLC)-beta isozymes and Rho guanine nucleotide exchange f
81 sciatic MBP(84-104) induced phospholipase C (PLC)-driven (females) and phosphoinositide 3-kinase-driv
82 rylated at threonine 505 by phospholipase C (PLC)-mediated signaling at the early stage of infection,
83 ceptors that signal through phospholipase C (PLC).
84 its role as a substrate for phospholipase C (PLC).
85 3) generated from PIP(2) by phospholipase C (PLC).
86 ) hydrolysis is mediated by phospholipase C (PLC).
87 uires signaling through the phospholipase C (PLC)/protein kinase C (PKC) pathway.
88 n alpha q subunit (Galphaq)/phospholipase C (PLC)beta1 activities and protein kinase C (PKC) phosphor
89 n alpha q subunit (Galphaq)/phospholipase C (PLC)beta1/protein kinase C (PKC) activity.
90 d LAT binds Grb2, Gads, and phospholipase C (PLC)gamma1 to mediate T cell activation, proliferation,
91                             Phospholipase C (PLC)s degrade phosphatidylinositol-4, 5-bisphosphate (PI
92 pathogenesis: two secreted phospholipases C (PLCs; PlcA and PlcB) and a surface protein (ActA).
93 everal signaling pathways, including calcium-PLC-PKC-PKD1 pathway, NF-kappaB pathway, and MAP kinase
94  that the incidence of primary liver cancer (PLC) has slowly declined over the last decades.
95                        Primary liver cancer (PLC) is the sixth most common cancer worldwide and the s
96  to the propagation of primary liver cancer (PLC) organoids from three of the most common PLC subtype
97 dy are major traits of primary liver cancer (PLC), which represent the second most common cause of ca
98 is of pulmonary lymphangitic carcinomatosis (PLC).
99      Here, we report that in mammalian cells PLC-generated IPs are rapidly recycled to inositol, and
100 fic subpopulation of proximal luminal cells (PLCs), enriched in the periurethral region of the develo
101    After activation of phospholipase Cgamma (PLC-gamma), TRPC1 mediated Ca(2+) entry and triggered pr
102                   The Portevin-Le Chatelier (PLC) effect is a phenomenon by which plastic slip in met
103 a limited number of pigmented lesion clinic (PLC) visits at dermatology centers.
104 PLC) organoids from three of the most common PLC subtypes: hepatocellular carcinoma (HCC), cholangioc
105 ervical spine posterior ligamentous complex (PLC).
106 tion of the antigen peptide-loading complex (PLC) and intrinsic tumor suppressors Rb and p53.
107     The MHC class I peptide loading complex (PLC) facilitates the assembly of MHC class I molecules w
108 lex class-I (MHC-I) peptide-loading complex (PLC) is a cornerstone of the human adaptive immune syste
109 al component of the peptide-loading complex (PLC), to which tapasin (TPN) recruits MHC class I (MHC I
110 the classical MHC-I peptide-loading complex (PLC).
111 ractions within the peptide-loading complex (PLC).
112  the percent loss of hydraulic conductivity (PLC) and the content of nonstructural carbohydrates (NSC
113 t percentage loss of hydraulic conductivity (PLC) of about 40%-60%, were broadly consistent with sate
114 ts, 73% (69/94) had histologically confirmed PLC.
115                                Consequently, PLCs control various cellular processes, and their aberr
116 ositol 4,5-bisphosphate used in conventional PLC assays and will enable high-throughput screens to id
117 of the parental tumors and the corresponding PLC-PDXs show high conservation of the molecular feature
118     Although the stroke perilesional cortex (PLC) has been hypothesized as a potential site for a BMI
119  neuronal ensembles in rat prelimbic cortex (PLC) and assess altered intrinsic excitability after 10
120 yer V pyramidal neurons in prelimbic cortex (PLC) of FosGFP-transgenic rats, we found that operant fo
121 edict that trees would have reached critical PLC in widespread areas (i.e. it projected a low mortali
122 d that AGB1 interacts with phospholipase Cs (PLCs), and Ca(o) induced InsP3 production in Col but not
123                  In turn, D1-mGlu5-dependent PLC signaling was causally linked with excessive activat
124 d PLC activity, indicating calcium-dependent PLCs are not upregulated by alcohol.
125                                For detecting PLC, sensitivity, specificity, and area under the receiv
126 itol 1,4,5-trisphosphate and diacylglycerol, PLC, unlike the other phospholipase C family members, is
127  activation of common (AC/PKA) and distinct (PLC/PKC, intra-/extra-cellular calcium, PI3K/MAPK/mTOR)
128 lipase C delta 1 pleckstrin homology domain (PLC delta1-PH), is completely inhibited in the presence
129 ted elevated LINK-A levels and downregulated PLC components.
130 Starch was converted to soluble sugar during PLC progression under drought, and the hydraulic conduct
131                     Phospholipase C-epsilon (PLC) plays a critical role in G-protein-coupled receptor
132 cell-surface D1-mGlu5 heteromers exacerbated PLC signaling and intracellular calcium release in respo
133 ic rats to ablate selectively Fos-expressing PLC neurons that were active during operant food self-ad
134 , we assessed the presence of signs favoring PLC on HRCT (smooth or nodular septal lines, subpleural
135                         Effect estimates for PLC and PSC remained similar after adjustment for PM and
136 , both yielded Kd values of about 200 nm for PLC-beta3-Galphaq binding.
137 ive value, and negative predictive value for PLC injuries were 55% (11 of 20), 97% (38 of 39), 92% (1
138 Although structures of isolated domains from PLC-gamma isozymes are available, these structures are i
139 etest-posttest study, patients with AMS from PLCs at 2 academic medical centers were recruited from J
140 ctive for some time following either Galphaq-PLC-beta3 dissociation or PLC-beta3-potentiated Galphaq
141 on-canonical signal transduction via Galphaq-PLC-IP3-Ca(2+) at the expense of canonical DRD1 Galphas
142 tivates a Src kinase/phospholipase C-gamma1 (PLC-gamma1) signaling pathway and Ca(2+) mobilization.
143 nt and activation of phospholipase C-gamma1 (PLC-gamma1), an important effector molecule for T cell a
144  and signal transducer phospholipase gamma2 (PLC-gamma2), and increased activation of PLC-gamma2 and
145 t bind Gbetagamma in a FRET-based Gbetagamma-PLC-beta binding assay.
146 ordingly, the ability of a tumor to generate PLC-PDX is predictive of poor prognosis.
147 ies (ROS) in multiple HCC cell lines (HepG2, PLC/PRF/5, and Hep3B).
148 es, suggesting a potential mechanism for how PLCs might interact with their target membranes.
149 aling response as evidenced by a decrease in PLC-beta activation and IP3R-mediated calcium store rele
150 fore, intrinsic movement of the PH domain in PLC-beta modulates Gbetagamma access to its binding site
151     Our reporting of a projected increase in PLC incidence to 2030 in 30 countries serves as a baseli
152                 Blocking PH domain motion in PLC-beta by cross-linking it to the EF hand domain inhib
153  is the minimal Gbetagamma binding region in PLC-beta3.
154 sus regarding the Gbetagamma binding site in PLC-beta.
155 a clinically useful tool that can be used in PLCs to help decrease worry about developing melanoma in
156 ple downstream signaling pathways, including PLC/PKC, Rho/Rac, and YAP.
157 ion process and estimate freeze-thaw-induced PLC.
158 ysically interacts with the TCR intermediate PLC-gamma1, targeting it for proteasomal degradation aft
159 e specific SK channel antagonist apamin into PLC increased Fos expression but had no effect on food s
160 of the human phospholipase C-gamma isozymes (PLC-gamma1, -gamma2) by tyrosine phosphorylation is fund
161        Here we identify PLCdelta4 as the key PLC isoform involved in regulation of TRPM8 channels in
162        Here we identify PLCdelta4 as the key PLC isoform involved in regulation of TRPM8 in sensory d
163 ibition or genetic disruption of Lck kinase, PLC-gamma1 or the T cell receptor complex inhibits light
164 d Gbetagamma and the Alexa Fluor 594-labeled PLC-beta pleckstrin homology (PH) domain, we demonstrate
165 e that resulted in reduced formation of LAT, PLC-gamma, and AKT microclusters.
166 lated PH domain can compete with full-length PLC-beta3 for binding Gbetagamma but not Galphaq, Using
167 y as a dominant-negative form of full-length PLC-beta3.
168 t high-resolution structure of a full-length PLC-gamma isozyme and use it to underpin a detailed mode
169 cs, including particle number (PNC), length (PLC), and surface area (PSC) concentrations, and myocard
170                                 Cross-linked PLC-beta does not bind Gbetagamma in a FRET-based Gbetag
171                     Rapid activation of mbGR/PLC/PKC further leads to activation of known biomarkers
172                           We found that mbGR/PLC/PKC signaling cascade exists in all cell types teste
173 signaling pathway involving Galphaq-mediated PLC activity is responsible for driving PKC-dependent ch
174 s greater than the EC50 for Galphaq-mediated PLC-beta3 activation and for the Galphaq GTPase-activati
175                             We projected new PLC cases to 2030 using age-period-cohort models (NORDPR
176 in PNC within the size range of 10 - 100 nm, PLC, and PSC were associated with an increase of MI 6 h
177 ntly higher in the PLC group than in the non-PLC group (P <= 0.0039).
178         However, it is unknown which nuclear PLC isoform is triggered by EGFR.
179          We hypothesized that the ability of PLC to function as a guanine nucleotide exchange factor
180 to assess Ca(2+) responses in the absence of PLC activity indicates that IP3 receptor modulation by P
181 um, resulting in a synergistic activation of PLC signaling by D1 and mGlu5 receptor agonists.
182 ns inhibited Galphaq-dependent activation of PLC-beta3 at least as effectively as a dominant-negative
183 eported the membrane-dependent activation of PLC-beta3 by Galphaq Therefore, XY-69 can replace radioa
184 bunits and did not inhibit the activation of PLC-beta3 by Gbeta1gamma2 In contrast, the peptide robus
185 the peptide robustly prevented activation of PLC-beta3 or p63RhoGEF by Galphaq; it also prevented G p
186              In turn, aberrant activation of PLC-gamma1 and PLC-gamma2 is implicated in inflammation,
187 a2 (PLC-gamma2), and increased activation of PLC-gamma2 and its downstream pathways following B cell
188 alphaq GTPase-activating protein activity of PLC-beta.
189 creased cancer fitness and aggressiveness of PLC may be achieved by enhancing tumoral genomic complex
190            We predicted the future burden of PLC in 30 countries around 2030.
191                            As a byproduct of PLC-mediated PIP(2) hydrolysis, protons have been shown
192                            Incident cases of PLC (International Classification of Diseases, Tenth Rev
193 rate interactions and as key determinants of PLC dynamics.
194  HRCT perform similarly for the diagnosis of PLC, with both being outperformed by (18)F-FDG PET/CT qu
195 F (CDC25 homology domain) and RA2 domains of PLC are required for long term protein kinase D (PKD) ac
196 learning increased intrinsic excitability of PLC Fos-expressing neuronal ensembles that play a role i
197                                  Exposure of PLC-PDXs to standards of care or therapeutic options alr
198                              The fraction of PLC-beta cross-linked is proportional to the fractional
199 surrogate to define genomic heterogeneity of PLC linked to chromosomal instability and evasion of imm
200                             The histology of PLC-PDXs is strikingly similar to that observed in prima
201  the G488R mutant, showing the importance of PLC-mediated PI(4,5)P2 depletion in this process.
202 nge intake involves a pathway independent of PLC activation.
203 re significantly associated with injuries of PLC in patients with spine cervical trauma.
204  measured the thermodynamics and kinetics of PLC-beta3 binding to Galphaq FRET and fluorescence corre
205            Here we show that localization of PLC to the Golgi is required for activation of PKD in th
206 ylation increases the speed and magnitude of PLC-gamma1 activation and enhances T cell sensitivity to
207         However, the regulatory mechanism of PLC is not yet understood in detail.
208 R signaling, resulting in phosphorylation of PLC-g1, calcium influx, ROS generation, upregulation of
209 2, infection leads to the phosphorylation of PLC-gamma1 at Ser 1248 immediately after infection and i
210   Diacylglycerol (DAG), the lipid product of PLC that activates conventional PKCs, is focally enriche
211 ogical features and metastatic properties of PLC-derived organoids are preserved in vivo.
212 nalysis, we found that the incidence rate of PLC and the mortality rates of severe end-stage liver di
213          Increases in new cases and rates of PLC are projected in both sexes.
214 mplications may lead to an increased risk of PLC that potentially offsets these gains is a concern.
215 not solvent-exposed in crystal structures of PLC-beta, necessitating conformational rearrangement to
216 ial staging of lung cancer with suspicion of PLC were included.
217               There was an underreporting of PLC diagnosed by noninvasive methods; the incidence was
218 ompleteness and assess the underreporting of PLC to the CR and to produce a more accurate estimate ba
219 ate the wide-ranging biomedical utilities of PLC-derived organoid models in furthering the understand
220 g candidates for reporting the activation of PLCs in live cells with high spatiotemporal resolution.
221 tool for measuring the real-time activity of PLCs as either purified enzymes or in cellular lysates.
222         Despite the widespread importance of PLCs in human biology and disease, it has been impossibl
223 mall hairpin RNA reduced both store-operated PLC activity and stimulation of TRPC1 SOCs.
224 ing either Galphaq-PLC-beta3 dissociation or PLC-beta3-potentiated Galphaq deactivation, is not suffi
225 ial control odor following intranasal OXT or PLC administration, respectively.
226 phatidylcholine-specific phospholipase C (PC-PLC) of L. monocytogenes, is a potent inhibitor of intra
227 ity through the enzymatic activity of its PC-PLC.
228 sure by activating a Wnt-like phospholipase (PLC)/ protein kinase C (PKC) signaling cascade.
229 ous domains, indicated that DAG activates PI-PLC whenever it can generate fluid domains to which the
230                      Shu1 cleavability by PI-PLC and its predicted hydropathy profile strongly sugges
231 hosphoinositide-specific phospholipase C (PI-PLC) is one of the earliest responses triggered by the r
232  of phosphatidylinositol-phospholipase C (PI-PLC) was studied with vesicles containing PI, either pur
233 hosphoinositide-specific phospholipase C (PI-PLC).
234 hatidylinositol-specific phospholipase C (PI-PLC).
235 t 22 degrees C, DAG at 33 mol % increased PI-PLC activity in all of the mixtures, but not in pure PI
236 s of a bacterial enzyme, PI-specific PLC (PI-PLC).
237 of plcA increased EV toxicity, suggesting PI-PLC reduced LLO activity.
238    The Arabidopsis (Arabidopsis thaliana) PI-PLC gene family is composed of nine members.
239 h the generation of small vesicles, which PI-PLC is known to degrade at higher rates.
240 ostsynaptic TRPC channel opening by the PI3K-PLC signalling pathway in POMC neurons enhances spontane
241 ilizing a randomized, double-blind, placebo (PLC)-controlled, within-subject functional MRI study des
242 utaneous injection of EX (5 mug) or placebo (PLC) 30 minutes before a 75-g oral glucose tolerance tes
243                                       Plasma PLC levels were higher in patients with KD and CC+CG rs6
244 C4 and TRPC5 channel function, the Galpha(q)-PLC pathway inhibits channel activity by depleting PI(4,
245 RPC5 channels are modulated by the Galpha(q)-PLC pathway.
246 ted Fos-expressing neuronal ensembles in rat PLC play an important role in learned operant food seeki
247 s at the level of G protein-coupled receptor PLC activity and/or IP3 metabolism to attenuate IP3 leve
248  hormone-dependent responses, do not require PLC.
249 ce, while bubble expansion and the resulting PLC occur during thawing.
250 netic lineage tracing, we show that RUNX1(+) PLCs are unaffected by androgen deprivation, and do not
251 llectively, our results reveal that RUNX1(+) PLCs is an intrinsic castration-resistant and self-susta
252 citation light induced a rapid (tau ~0.8 s), PLC-dependent decrease in fluorescence, representing dep
253 e evidence for the involvement of a specific PLC isoform in the regulation of cold sensitivity in mic
254 roperties of a bacterial enzyme, PI-specific PLC (PI-PLC).
255 spholipase C (PLC), but neither the specific PLC isoform nor the in vivo relevance of this regulation
256 s of G(q)alpha and G11alpha, which stimulate PLC, leads to severe hyperphagic obesity, increased line
257 malize the differences in hormone-stimulated PLC activity, indicating calcium-dependent PLCs are not
258 stent with a Kd of 200 nm We determined that PLC-beta3 hysteresis, whereby PLC-beta3 remains active f
259          These results provide evidence that PLC-PDX preclinical platform can strongly contribute to
260                                          The PLC effect is thought to be fundamentally caused by the
261                                          The PLC functions to facilitate and optimize MHC I-mediated
262                                          The PLC has a layered structure, with two editing modules fo
263 tor GDP-beta-S, anti-Galphaq antibodies, the PLC inhibitor U73122, and the PKC inhibitor GF109203X al
264  In contrast to all other TRPC channels, the PLC product diacylglycerol (DAG) is not sufficient for c
265 ic method, should be reported to the CR, the PLC incidence may not reflect the true rate.
266 , delaying MHC class I dissociation from the PLC and their transit through the secretory pathway.
267  to induce MHC class I dissociation from the PLC, we investigated the interaction of ATP with the cha
268  a rat stroke model, we demonstrate here the PLC's capacity for neuroprosthetic control and physiolog
269                             Importantly, the PLC treatment did not decrease the high lateral resoluti
270 background, were significantly higher in the PLC group than in the non-PLC group (P <= 0.0039).
271 t, despite the disrupted connectivity in the PLC, it may serve as an effective target for neuroprosth
272          Tapasin plays a central role in the PLC, stabilizing the MHC-I binding groove in a conformat
273 e showed that signaling abnormalities in the PLC/IP3/PKC/ERK pathway (phospholipase C/inositol 1,4,5-
274 complex, we report an atomistic model of the PLC and study its conformational dynamics on the multimi
275 R) luminal, calcium-binding component of the PLC that is known to bind ATP.
276 nesis, we identify a hydrophobic face of the PLC-beta PH domain as the Gbetagamma binding interface.
277     Diacylglycerol (DAG), the product of the PLC-catalyzed PI(4,5)P(2) hydrolysis, activates protein
278  model also explains why mutant forms of the PLC-gamma isozymes found in several cancers have a wide
279  that the FAM151 proteins are members of the PLC-like phosphodiesterase superfamily.
280 eic acids or GPCR antagonists stabilized the PLC components, Rb and p53, and sensitized mammary gland
281 esence of extracellular Ca(2+), and that the PLC-inositol 1,4,5-trisphosphate pathway, which controls
282 phosphate (PIP2), the mechanism by which the PLC pathway activates TRPC4/C5 remains unclear.
283 es suggest a functional asymmetry within the PLC resulting in greater significance of the TAP2/TPN in
284             The results show that 98% of the PLCs reported to the CR were histologically verified; 80
285 e G (alphaq) protein that does not couple to PLC inhibited TRPM8 activity, and in cells expressing th
286 g by G(q)-protein-coupled receptors triggers PLC-mediated hydrolysis of PIP(2) into inositol 1,4,5-tr
287 rea that was disrupted by stress odors under PLC.
288                   We propose that unliganded PLC-beta exists in equilibrium between a closed conforma
289 e host cytosol, WT L. monocytogenes utilized PLCs and ActA to avoid subsequent xenophagy.
290 e to Coronin-1-dependent calcium release via PLC-gamma1 signaling, which releases PI3K-dependent supp
291 philic lipids differed for WD and PLA2 ED vs PLC and 3G ED.
292 was observed on ATGU (EX = 1.16 +/- 0.15 vs. PLC = 1.36 +/- 0.13 [mumol/min/L]/[mumol/min/kg]).
293 PK-dependent presynaptic inhibition, whereas PLC-mediated GABAergic feedback inhibition remains respo
294 etermined that PLC-beta3 hysteresis, whereby PLC-beta3 remains active for some time following either
295  data provide a molecular mechanism by which PLC mediates sustained signaling and by which astrocytes
296          An abnormal PFP was associated with PLC (P < .001) and arch (P = .006) injuries but not with
297 nversion of NSCs is strongly associated with PLC variations during dehydration and rehydration proces
298 ake were more often present in patients with PLC (P < 0.009).
299 ely dependent on Gbetagamma interaction with PLCs leading to InsP3 production.
300 ric liver cancer patient-derived xenografts (PLC-PDXs) from 20 hepatoblastomas (HBs), 1 transitional

 
Page Top